Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
AUTODESK, INC. ANNOUNCES FISCAL 2027 SECOND QUARTER RESULTS
-
Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer
-
Workday Announces Fiscal 2027 Second Quarter Financial Results
-
Asure Celebrates 50 Small and Mid-Sized Business Honorees at 2026 Asure50 Awards
-
AM Best Removes from Under Review With Positive Implications and Upgrades Issuer Credit Rating of ECM Insurance Group Members
-
NetApp to Participate in Upcoming Conferences
-
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
-
Darden Restaurants to Release Fiscal 2027 First Quarter Results on September 24, 2026
-
Blend Honors Seven Customers With Best in Banking Awards at Forum 2026
-
Adicet Bio Announces FDA Clearance of IND Application for ADI-212
-
Branford Castle Charges Ahead with Sale of Vitrek
-
Lambda Closes $926 Million Senior Secured Term Loan B Facility, Backing GPU Deployment for an Investment-Grade Customer
-
Comcast to Participate in Goldman Sachs Investor Conference
-
WTW Announces Regular Quarterly Dividend
-
Music Beats Cancer Launches “Thumbs Up for a Cure” to Support the Next Generation of Childhood Cancer Treatments
-
MHIET Establishes Hydrogen Co-Firing Specifications for the KU Series Gas Engine for Power Generation
-
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
-
FlyersRights Responds to DOT Proposed Roll Back of the Full Fare Advertising Rule
-
Floki Gains 33% in a Week, Shiba Inu Stumbles, Apeing Steps Into Best Meme Coin Presale Spotlight – Get Whitelisted Now!
-
Bitcoin, Ethereum or AlphaPepe? Best Crypto To Buy Now Debate Heats Up as Retail Hunts the Next 10x–100x Setup
-
Crypto Presale to Watch: Ethereum and Avalanche Set the Scene as IceBull Starts Its Stage 1 Run
-
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Moves Myelin-Protecting MS Therapy to Phase 2 Development
-
PruittHealth Celebrates Senior CNA Graduates at Walt Disney World® Resort
-
Walker-Miller Energy Services Named No. 1045 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies
-
American College of Lifestyle Medicine Annual Conference to highlight lifestyle medicine implementation, clinical value and successful behavior change
-
Virginia American Water President Addresses ASCE 2026 Report Card for Virginia's Infrastructure
-
StratEdge Opens New Facility in Poway
-
Las Vegas Film Festival Opens 2027 Call for Entries, Announcing Distribution Awards and Expanded New Media Categories
-
Hoomanely Unveils AI-Native Platform to Build the Health Intelligence Layer for Animals
-
Natuzzi Received Delisting Notice From NYSE
-
Novarad Updates NovaPACS EI Customers Worldwide to 9.1, a Major Security Upgrade
-
First Keystone Corporation Announces Third Quarter Dividend
-
NorthStar Gaming Acknowledges AGCO Order of Monetary Penalty
-
Harbor Capital Advisors Expands ETF Lineup with the Harbor Short Term Treasury ETF (HBIL)
-
VERAXA Biotech AG (NASDAQ: VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
-
Asset Panda Helps Law Enforcement Agencies Strengthen Chain of Custody and Evidence Accountability With Digital Asset Management
-
AutoTrust CEO Dave Mondragon: Scale Is Now the Deciding Factor for Dealers
-
Alurion Launches Amargosa PFS Program to Advance a Scalable Atlantic-Basin Bauxite Project
-
Alex Morgan and TOGETHXR Partner with Bet on Her App to Centralize Women's Sports Fandom
-
Homestyle Direct Dramatically Expands Freezer Capacity with New Lebanon, Tennessee Facility
-
Regenerative Hydrogel Is Redefining Cartilage Repair as Regentis Advances GelrinC
-
Tagup Expands AI-Powered Logistics to Theater Sustainment in Support of U.S. Marine Corps Forces, Pacific
-
PICKLR IN CENTRAL INDIANA INTRODUCES MINOR LEAGUE TEAM IN AFFILIATION WITH ST. LOUIS SHOCK MLP
-
Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising
-
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
-
Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
-
Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
-
Mercedes-Benz of Arrowhead Offers Cars with Massage Seats
-
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
-
CARZ4US Named One of 100 Top Digital Dealerships in the United States for 2026
